Photo of Andreas K. Lauer, M.D.

Andreas K. Lauer M.D.

Dr. Lauer completed his medical school and internship at University of Oklahoma Health Sciences Center.  He completed his residency training in ophthalmology and vitreoretinal fellowship training at Casey Eye Institute - Oregon Health & Science University.  He specializes in the care of patients with medical and surgical diseases of the retina and vitreous.  He has served as ophthalmology residency program director, retina fellowship program director and chief of the vitreoretinal division.  He has served as clinical trials investigator in the areas of ocular gene therapy, age-related macular degeneration, inherited retinal diseases, diabetic retinopathy, retinal vein occlusions, and retinopathy of prematurity.  Dr. Lauer serves as a director for the American Board of Ophthalmology and is chair of its maintenance of certification program.  Dr. Lauer is vice-chair for the Accreditation Council for Graduate Medical Education Review Committee for Ophthalmology and is a member of the Association of University Professors in Ophthalmology.  In 2018, Dr. Lauer was appointed as Chair for the Department of Ophthalmology. 

Education

  • B.A., University of Rochester, Rochester New York 1988
  • M.D., University of Oklahoma, Oklahoma City Oklahoma 1994
  • Internship:

    • University of Oklahoma, Internal Medicine, 1995
  • Residency:

    • Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, 1999
  • Fellowship:

    • Retina and vitreous fellowship, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, 2001
  • Certifications:

    • American Board of Ophthalmology

Publications

  • "Molecular diagnosis and ocular imaging of varicella zoster virus associated neuroretinitis." American Journal of Ophthalmology Case Reports  In: , Vol. 11, 01.09.2018, p. 146-148.
  • "Classification of choroidal neovascularization using projection-resolved optical coherence tomographic angiography." Investigative Ophthalmology and Visual Science  In: , Vol. 59, No. 10, 01.08.2018, p. 4285-4291.
  • "Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema." Ophthalmology  In: , Vol. 125, No. 7, 01.07.2018, p. 1054-1063.
  • "Comparison of monthly vs treat-and-extend regimens for individuals with macular edema who respond well to anti-vascular endothelial growth factor medications : Secondary outcomes from the SCORE2 randomized clinical trial." JAMA Ophthalmology  In: , Vol. 136, No. 4, 01.04.2018, p. 337-345.
  • "Allogeneic iPSC-derived RPE cell graft failure following transplantation into the subretinal space in nonhuman primates." Investigative Ophthalmology and Visual Science  In: , Vol. 59, No. 3, 01.03.2018, p. 1374-1383.
  • "Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema : A DRCR network phase 2 randomized clinical trial." JAMA Ophthalmology  In: , Vol. 136, No. 1, 01.01.2018, p. 29-38.
  • "Projection-resolved optical coherence tomography angiography exhibiting early flow prior to clinically observed retinal angiomatous proliferation." American Journal of Ophthalmology Case Reports  In: , Vol. 8, 01.12.2017, p. 53-57.
  • "CLINICOPATHOLOGIC CORRELATION of RETINAL ANGIOMATOUS PROLIFERATION TREATED with RANIBIZUMAB." Retina  In: , Vol. 37, No. 8, 01.08.2017, p. 1620-1624.
  • "Sensitivity and Specificity of OCT Angiography to Detect Choroidal Neovascularization." Kidney International Reports  In: , Vol. 2, No. 4, 01.07.2017, p. 294-303.
  • "A case of ophthalmomyiasis interna in the Pacific Northwest." American Journal of Ophthalmology Case Reports  In: , Vol. 6, 01.06.2017, p. 11-14.
  • "SUBRETINAL CELL-BASED THERAPY : An Analysis of Surgical Variables to Increase Cell Survival." Retina  In: , 16.01.2017.
  • "Lentiviral vector gene transfer of endostatin/angiostatin for macular degeneration (GEM) study." Human Gene Therapy  In: , Vol. 28, No. 1, 01.01.2017, p. 99-111.
  • "Visualization of 3 distinct retinal plexuses by projection-resolved optical coherence tomography angiography in diabetic retinopathy." JAMA Ophthalmology  In: , Vol. 134, No. 12, 01.12.2016, p. 1411-1419.
  • "Optical coherence tomographic angiography of choroidal neovascularization ill-defined with fluorescein angiography." British Journal of Ophthalmology  In: , 01.12.2016.
  • "Long-term surgical outcomes of retinal detachment associated with acute retinal necrosis." Ophthalmic Surgery Lasers and Imaging Retina  In: , Vol. 47, No. 7, 01.07.2016, p. 660-664.
  • "Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy." JAMA Ophthalmology  In: , Vol. 134, No. 4, 01.04.2016, p. 367-373.
  • "Detection of nonexudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography." Retina  In: , Vol. 35, No. 11, 27.10.2015, p. 2204-2211.
  • "Optical coherence tomography angiography features of diabetic retinopathy." Retina  In: , Vol. 35, No. 11, 27.10.2015, p. 2371-2376.
  • "Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials." Ophthalmology  In: , Vol. 122, No. 9, 01.09.2015, p. 1846-1853.
  • "Vitreous veils associated with congenital X-linked retinoschisis." JAMA Ophthalmology  In: , Vol. 133, No. 8, 01.08.2015.
  • "Global health training in ophthalmology residency programs." Journal of Surgical Education  In: , Vol. 72, No. 4, 01.07.2015, p. e52-e59.
  • "The global education network for retinopathy of prematurity (Gen-rop) : Development, implementation, and evaluation of a novel tele-education system (an American ophthalmological society thesis)." Transactions of the American Ophthalmological Society  In: , Vol. 113, 2015.
  • "Reply." Retina  In: , Vol. 35, No. 7, 2015, p. e33-e34.
  • "Aflibercept : An update on recent milestones achieved." Drugs of Today  In: , Vol. 50, No. 12, 01.12.2014, p. 779-790.
  • "Polypoidal choroidal vasculopathy in white patients." Retina  In: , Vol. 34, No. 11, 12.11.2014, p. 2185-2191.
  • "Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab." Clinical Ophthalmology  In: , Vol. 8, 01.09.2014, p. 1675-1679.
  • "Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome." Ophthalmic Surgery Lasers and Imaging Retina  In: , Vol. 45, No. 5, 01.09.2014, p. 399-407.
  • "Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration." British Journal of Ophthalmology  In: , Vol. 98, No. 9, 2014, p. 1205-1207.
  • "Postoperative rhabdomyolysis following pars-plana vitrectomy under general anesthesia." Clinical Ophthalmology  In: , Vol. 7, 31.07.2013, p. 1557-1558.
  • "Adalimumab therapy for refractory uveitis : Results of a multicentre, open-label, prospective trial." British Journal of Ophthalmology  In: , Vol. 97, No. 4, 04.2013, p. 481-486.

Additional information

Edit profile